Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: A randomised, multicentre trial

Lancet

Volumn 359, Issue 9315, 2002, Pages 1365-1372

  Adjuik, M ^a   Agnamey, P ^b   Babiker, A ^c   Borrmann, S ^e,f   Brasseur, P ^b   Cisse, M ^d   Cobelens, F ^g   Diallo, S ^h   Faucher, J F ^e   Garner, P ⁱ   Gikunda, S ^j   Kremsner, P G ^e,f   Krishna, S ^e,k   Lell, B ^e,f   Loolpapit, M ^j   Matsiegui, P B ^e   Missinou, M A ^e,f   Mwanza, J ^j   Ntoumi, F ^e   Olliaro, P ^l   Osimbo, P ^m   Rezbach, P ^e,f   Some, E ^j   Taylor, W R J ^l   more..

^a NAVRONGO HEALTH RESEARCH CENTRE   (Ghana)

^b UNIVERSITÉ DE ROUEN   (France)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d Centre Hospitalier   (Senegal)

^e ALBERT SCHWEITZER HOSPITAL   (Gabon)

^f UNIVERSITY OF TÜBINGEN   (Germany)

^g ACADEMIC MEDICAL CENTER   (Netherlands)

^h UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

ⁱ LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^j AMREF HEALTH AFRICA   (Kenya)

^k ST GEORGE S HOSPITAL   (United Kingdom)

^l WORLD HEALTH ORGANIZATION   (Switzerland)

^m MINISTRY OF HEALTH   (Kenya)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTESUNATE; PLACEBO;

AFRICA; ARTICLE; CHEMOTHERAPY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CHOICE; DRUG EFFECT; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; DRUG SCREENING; DRUG TOLERANCE; FEMALE; GAMETOCYTE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MULTICENTER STUDY; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION;

EID: 0037140198     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)08348-4     Document Type: Article

References (31)

1. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population
2. Impact of chloroquine resistance on malaria morbidity
3. The efficacy of pyrimethamine-sulfadoxine (Fansidar) in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children
4. Strategies for the prevention of antimalarial drug resistance: Rationale for combination chemotherapy for malaria
5. Delaying antimalarial drug resistance with combination chemotherapy
6. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: A prospective study
7. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: A double-blind, randomised, controlled trial
8. Systematic review of amodiaquine treatment in uncomplicated malaria
9. Adverse effects of antimalarials: An update
10. Amodiaquine remains effective for treating uncomplicated malaria in west and central Africa
11. Test in vivo de chimiosensibilité de Plasmodium falciparum à la chloroquine au Sénégal: Évolution de la résistance et estimation de l'efficacité thérapeutique
12. Mosquito distribution and entomological inoculation rates in three malaria-endemic areas in Gabon
13. Atovaquone and proguanil for Plasmodium falciparum malaria
14. Severe and complicated malaria
15. Severe falciparum malaria
16. Comparison of methods for the rapid laboratory assessment of children with malaria
17. PCR typing of field isolates of Plasmodium falciparum
18. Adverse drug reactions: Definitions, diagnosis, and management
19. Test-based exact confidence intervals for the difference of two binomial proportions
20. What is meant by intention to treat analysis?
21. Resistance of malarial parasites to drugs
22. Risk factors for gametocyte carriage in uncomplicated falciparum malaria
23. Ascertainment of risk of serious adverse reactions associated with chemoprophylactic antimalarial drugs
24. Acute asymptomatic hepatitis in a healthy normal volunteer exposed to two oral doses of amodiaquine and artesunate
25. Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: A randomised trial
26. Evaluation de l'efficacité et de la tolerance de l'amodiaquine versus chloroquine dans le traitement de l'acces palustre simple chez l'enfant au Gabon
27. A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children
28. Treatment of African children with uncomplicated falciparum malaria with a new antimalarial drug, CGP 56697
29. Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria
30. A randomized, double-blind, parallel-group, comparative safety, and efficacy trial of oral co-artemether versus oral chloroquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in adults in India
31. Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years